Quarterly Report • Nov 9, 2022
Quarterly Report
Open in ViewerOpens in native device viewer

Unaudited, consolidated figures following IFRS accounting policies.
| Q3 2022 | Q3 2021 | 9M 2022 | 9M 2021 | |
|---|---|---|---|---|
| Revenue | 474 | 439 | 1,367 | 1,276 |
| Cost of sales | (339) | (322) | (972) | (906) |
| Gross profit | 135 | 118 | 395 | 370 |
| Selling expenses | (62) | (56) | (184) | (169) |
| Administrative expenses | (47) | (37) | (132) | (116) |
| R&D expenses | (25) | (22) | (73) | (71) |
| Net impairment loss on trade and other receivables, including contract assets |
(1) | (1) | (1) | (1) |
| Other & sundry operating income | 7 | 5 | 20 | 31 |
| Other & sundry operating expenses | (12) | (7) | (35) | (18) |
| Results from operating activities | (7) | (1) | (10) | 26 |
| Interest income (expense) - net Interest income |
- 1 |
- - |
- 2 |
(1) 1 |
| Interest expense | (1) | (1) | (2) | (3) |
| Other finance income (expense) - | (6) | (3) | (14) | (6) |
| net Other finance income |
- | - | 6 | 6 |
| Other finance expense | (6) | (3) | (20) | (12) |
| Net finance costs | (5) | (4) | (15) | (7) |
| Share of profit of associates, net of tax | - | - | - | - |
| Profit (loss) before income taxes | (12) | (4) | (24) | 18 |
| Income tax expenses | (5) | (1) | (12) | (15) |
| Profit (loss) for the period | (17) | (5) | (37) | 4 |
| Profit (loss) attributable to: | ||||
| Owners of the Company | (18) | (5) | (39) | 5 |
| Non-controlling interests | 1 | - | 2 | (1) |
| Results from operating activities | (7) | (1) | (10) | 26 |
| Restructuring and non-recurring items | (13) | (7) | (37) | (5) |
| Adjusted EBIT | 7 | 6 | 27 | 31 |
| Earnings per Share Group (Euro) | (0.12) | (0.03) | (0.25) | 0.03 |

September 2022 (in million Euro) Unaudited, consolidated figures following IFRS accounting policies.
| 9M 2022 | 9M 2021 | |
|---|---|---|
| Profit / (loss) for the period | (37) | 4 |
| Other Comprehensive Income, net of tax | ||
| Items that are or may be reclassified subsequently to profit or loss: | ||
| Exchange differences: | 50 | 20 |
| Exchange differences on translation of foreign operations | 50 | 20 |
| Cash flow hedges: | (4) | (5) |
| Effective portion of changes in fair value of cash flow hedges | (7) | 4 |
| Changes in the fair value of cash flow hedges reclassified to profit or loss | 3 | (2) |
| Adjustments for amounts transferred to initial carrying amount of hedged items | - | (8) |
| Income taxes | - | 1 |
| Items that will not be reclassified subsequently to profit or loss: | 114 | 78 |
| Equity investments at fair value through OCI – change in fair value | (3) | 2 |
| Remeasurements of the net defined benefit liability | 129 | 82 |
| Income tax on remeasurements of the net defined benefit liability | (13) | (6) |
| Total Other Comprehensive Income for the period, net of tax | 160 | 92 |
| Total Comprehensive Income for the period, net of tax | 123 | 96 |
| Attributable to | ||
| Owners of the Company | 118 | 94 |
| Non-controlling interests | 5 | 2 |

September 2022 (in million Euro) Unaudited, consolidated figures following IFRS accounting policies.
| Q3 2022 | Q3 2021 | |
|---|---|---|
| Profit / (loss) for the period | (17) | (5) |
| Other Comprehensive Income, net of tax | ||
| Items that are or may be reclassified subsequently to profit or loss: | ||
| Exchange differences: | 18 | 5 |
| Exchange differences on translation of foreign operations | 18 | 5 |
| Cash flow hedges: | (2) | (2) |
| Effective portion of changes in fair value of cash flow hedges | (3) | 1 |
| Changes in the fair value of cash flow hedges reclassified to profit or loss | 1 | - |
| Adjustments for amounts transferred to initial carrying amount of hedged items | - | (4) |
| Income taxes | - | 1 |
| Items that will not be reclassified subsequently to profit or loss: | (3) | (3) |
| Equity investments at fair value through OCI – change in fair value | (1) | - |
| Remeasurements of the net defined benefit liability | - | - |
| Income tax on remeasurements of the net defined benefit liability | (2) | (3) |
| Total Other Comprehensive Income for the period, net of tax | 13 | (1) |
| Total Comprehensive Income for the period, net of tax | (4) | (6) |
| Attributable to | ||
| Owners of the Company | (6) | (7) |
| Non-controlling interests | 2 | 1 |

Unaudited, consolidated figures following IFRS accounting policies.
| 30/09/2022 | 31/12/2021 | |
|---|---|---|
| Non-current assets | 824 | 756 |
| Goodwill | 309 | 280 |
| Intangible assets | 36 | 13 |
| Property, plant and equipment | 131 | 129 |
| Right-of-use assets | 71 | 68 |
| Investments in associates | 1 | 1 |
| Other financial assets | 4 | 8 |
| Assets related to post-employment benefits | 54 | 40 |
| Trade receivables | 9 | 12 |
| Receivables under finance leases | 78 | 70 |
| Other assets | 9 | 11 |
| Deferred tax assets | 121 | 124 |
| Current assets | 1,279 | 1,339 |
| Inventories | 561 | 418 |
| Trade receivables | 311 | 307 |
| Contract assets | 93 | 76 |
| Current income tax assets | 58 | 63 |
| Other tax receivables | 28 | 19 |
| Other financial assets | 1 | 2 |
| Receivables under finance lease | 15 | 30 |
| Other receivables | 7 | 4 |
| Other assets | 17 | 18 |
| Derivative financial instruments | 9 | 1 |
| Cash and cash equivalents | 178 | 398 |
| Non-current assets held for sale | 2 | 3 |
| TOTAL ASSETS | 2,103 | 2,095 |

| 30/09/2022 | 31/12/2021 | |
|---|---|---|
| Total equity | 782 | 685 |
| Equity attributable to owners of the company | 729 | 632 |
| Share capital | 187 | 187 |
| Share premium | 210 | 210 |
| Retained earnings | 1,224 | 1,284 |
| Reserves | (7) | (1) |
| Translation reserve | 31 | (15) |
| Post-employment benefits: remeasurements of the net defined benefit liability | (917) | (1,033) |
| Non-controlling interests | 53 | 54 |
| Non-current liabilities | 682 | 812 |
| Liabilities for post-employment and long-term termination benefit plans | 600 | 735 |
| Other employee benefits | 11 | 11 |
| Loans and borrowings | 50 | 46 |
| Provisions | 12 | 12 |
| Deferred tax liabilities | 8 | 6 |
| Contract liabilities | - | 1 |
| Other non-current liabilities | - | - |
| Current liabilities | 639 | 597 |
| Loans and borrowings | 29 | 27 |
| Provisions | 32 | 42 |
| Trade payables | 274 | 252 |
| Contract liabilities | 130 | 111 |
| Current income tax liabilities | 30 | 28 |
| Other tax liabilities | 16 | 28 |
| Other payables | 7 | 9 |
| Employee benefits | 99 | 99 |
| Other current liabilities | 1 | - |
| Derivative financial instruments | 22 | 2 |
| TOTAL EQUITY AND LIABILITIES | 2,103 | 2,095 |

Unaudited, consolidated figures following IFRS accounting policies.
| 9M 2022 | 9M 2021 | Q3 2022 | Q3 2021 | |
|---|---|---|---|---|
| Profit (loss) for the period | (37) | 4 | (17) | (5) |
| Income taxes | 12 | 15 | 5 | 1 |
| Share of (profit)/loss of associates, net of tax | - | - | - | - |
| Net finance costs | 15 | 7 | 5 | 4 |
| Operating result | (10) | 26 | (7) | (1) |
| Depreciation & amortization | 26 | 26 | 9 | 9 |
| Depreciation & amortization on right-of-use assets | 21 | 21 | 7 | 6 |
| Impairment losses on goodwill, intangibles and PP&E | - | - | - | - |
| Impairment losses on right-of-use assets | - | - | - | - |
| Exchange results and changes in fair value of derivates | 13 | 4 | 5 | 2 |
| Recycling of hedge reserve | 3 | (2) | 1 | - |
| Government grants and subsidies | (3) | (8) | (1) | (3) |
| (Gains)/losses on the sale of intangible assets and PP&E and remeasurement of leases Result on the disposal of discontinued operations |
- - |
(7) - |
- - |
- - |
| Expenses for defined benefit plans & long-term termination benefits | 28 | 21 | 6 | 7 |
| Accrued expenses for personnel commitments | 51 | 54 | 21 | 19 |
| Write-downs/reversal of write-downs on inventories | 8 | 8 | 1 | 2 |
| Impairments/reversal of impairments on receivables | 1 | 1 | 1 | 1 |
| Additions/reversals of provisions | 5 | (4) | 1 | 1 |
| Operating cash flow before changes in working capital | 142 | 138 | 45 | 43 |
| Change in inventories | (121) | (88) | (20) | (24) |
| Change in trade receivables | 29 | 10 | 15 | (4) |
| Change in contract assets | (8) | (7) | 5 | (4) |
| Change in trade working capital assets | (101) | (85) | - | (33) |
| Change in trade payables | (9) | 45 | (5) | 12 |
| Change in contract liabilities | 8 | 12 | (6) | (3) |
| Changes in trade working capital liabilities | (2) | 56 | (11) | 9 |
| Changes in trade working capital | (103) | (28) | (10) | (23) |

| 9M 2022 | 9M 2021 | Q3 2022 | Q3 2021 | |
|---|---|---|---|---|
| Cash out for employee benefits | (112) | (235) | (25) | (29) |
| Cash out for provisions | (17) | (31) | (5) | (6) |
| Changes in lease portfolio | 10 | 8 | 1 | 4 |
| Changes in other working capital | (15) | 2 | (8) | (1) |
| Cash settled operating derivatives | (6) | 8 | (3) | 3 |
| Cash generated from operating activities | (100) | (137) | (5) | (9) |
| Income taxes paid | (4) | (5) | 2 | (4) |
| Net cash from / (used in) operating activities | (104) | (142) | (3) | (12) |
| Capital expenditure | (23) | (19) | (10) | (5) |
| Proceeds from sale of intangible assets and PP&E | 3 | 11 | 2 | - |
| Acquisition of associates and subsidiaries, net of cash acquired | (48) | - | - | - |
| Disposal of discontinued operations, net of cash disposed of | (4) | - | (3) | - |
| Repayment of loans granted to 3rd parties | - | 9 | - | 8 |
| Interests received | 4 | 2 | 2 | 1 |
| Dividends received | - | - | - | - |
| Net cash from / (used in) investing activities | (68) | 3 | (9) | 4 |
| Interests paid | (3) | (3) | (1) | (1) |
| Dividends paid to non-controlling interests | (6) | - | (1) | - |
| Interests and dividends paid | (10) | (3) | (2) | (1) |
| Purchase of treasury shares | (21) | (21) | - | (12) |
| Proceeds from borrowings | 3 | 1 | 3 | 1 |
| Repayment of borrowings | (2) | (3) | (1) | - |
| Payment of finance leases | (23) | (21) | (8) | (6) |
| Changes in borrowings | (22) | (23) | (5) | (5) |
| Proceeds / (payment) of derivatives | (5) | 2 | - | 1 |
| Other financing income / (costs) received/paid | 3 | 1 | (1) | - |
| Net cash from / used in financing activities | (55) | (43) | (9) | (18) |
| Net increase / (decrease) in cash & cash equivalents | (228) | (182) | (22) | (25) |
| Cash & cash equivalents at the start of the period | 398 | 585 | 191 | 427 |
| Net increase / (decrease) in cash & cash equivalents | (228) | (182) | (22) | (25) |
| Effect of exchange rate fluctuations on cash held | 8 | (2) | 9 | (1) |
| Gains/(losses) on marketable securities | - | (1) | - | - |
| Cash & cash equivalents at the end of the period | 178 | 400 | 178 | 400 |

Unaudited, consolidated figures following IFRS accounting policies.
| ATTRIBUTABLE TO OWNERS OF THE COMPANY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| in million Euro | Share capital | Share premium | Retained earnings | Reserve for own shares |
Revaluation reserve |
Hedging reserve | of the net defined Remeasurement benefit liability |
Translation reserve |
Total | CONTROLLING INTERESTS NON |
TOTAL EQUITY |
| Balance at January 1, 2021 | 187 | 210 | 1,412 | (82) | - | 7 | (1,122) | (42) | 570 | 51 | 620 |
| Comprehensive income for the period | |||||||||||
| Profit (loss) for the period | - | - | 5 | - | - | - | - | - | 5 | (1) | 4 |
| Other comprehensive income, net of tax | - | - | - | - | 2 | (5) | 75 | 17 | 89 | 3 | 92 |
| Total comprehensive income for the period | - | - | 5 | - | 2 | (5) | 75 | 17 | 94 | 2 | 96 |
| Transactions with owners, recorded directly in equity |
|||||||||||
| Dividends | - | - | - | - | - | - | - | - | - | - | - |
| Purchase of own shares | - | - | - | (21) | - | - | - | - | (21) | - | (21) |
| Cancellation of own shares | - | - | (103) | 103 | - | - | - | - | - | - | - |
| Total transactions with owners, recorded directly in equity |
- | - | (103) | 82 | - | - | - | - | (21) | - | (21) |
| Balance at September 30, 2021 | 187 | 210 | 1,315 | - | 2 | 1 | (1,047) | (25) | 643 | 53 | 695 |
| Balance at January 1, 2022 | 187 | 210 | 1,284 | - | 2 | (2) | (1,033) | (15) | 632 | 54 | 685 |
| Comprehensive income for the period | |||||||||||
| Profit (loss) for the period | - | - | (39) | - | - | - | - | - | (39) | 2 | (37) |
| Other comprehensive income, net of tax | - | - | - | - | (3) | (4) | 117 | 46 | 157 | 3 | 160 |
| Total comprehensive income for the period | - | - | (39) | - | (3) | (4) | 117 | 46 | 118 | 5 | 123 |
| Transactions with owners, recorded directly in equity |
|||||||||||
| Dividends | - | - | - | - | - | - | - | - | - | (5) | (5) |
| Purchase of own shares | - | - | - | (21) | - | - | - | - | (21) | - | (21) |
| Cancellation of own shares | - | - | (21) | 21 | - | - | - | - | - | - | - |
| Total transactions with owners, recorded directly in equity |
- | - | (21) | - | - | - | - | - | (21) | (5) | (26) |
| Balance at September 30, 2022 | 187 | 210 | 1,224 | - | (1) | (6) | (917) | 31 | 729 | 53 | 782 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.